203 related articles for article (PubMed ID: 798727)
21. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
Ishaque M; Sticht-Groh V; Togola D
Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
[TBL] [Abstract][Full Text] [Related]
22. Growth of the ICRC bacilli in the foot-pad of mice.
Bapat CV; Modak MS
Lepr India; 1978 Apr; 50(2):144-55. PubMed ID: 353383
[TBL] [Abstract][Full Text] [Related]
23. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
Sreevatsa ; Katoch VM
Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
[TBL] [Abstract][Full Text] [Related]
24. Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase.
Matsuo E; Skinsnes OK; Chang PH
Int J Lepr Other Mycobact Dis; 1975; 43(1):1-13. PubMed ID: 1099016
[TBL] [Abstract][Full Text] [Related]
25. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
26. The effect of dihydrofolate reductase inhibitors on Mycobacterium Leprae in the mouse foot pad.
Gelber RH; Levy L
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):124-32. PubMed ID: 776847
[No Abstract] [Full Text] [Related]
27. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
29. Rifampin in drug-incorporated diet: effect of duration and temperature of storage. Relevance to drug-susceptibility testing in mice inoculated with M. leprae.
Abraham B; Cariappa A; Chacko CJ
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):68-75. PubMed ID: 2030317
[TBL] [Abstract][Full Text] [Related]
30. Effect of diet on growth of M. leprae in mouse footpads.
Foster RL; Sanchez A; Small C; Lau BH; Stuyvesant W; Foster FN; Baldwin BE
Indian J Lepr; 1989 Jul; 61(3):360-6. PubMed ID: 2671180
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal action of dapsone against Mycobacterium leprae in mice.
Levy L
Antimicrob Agents Chemother; 1976 Apr; 9(4):614-7. PubMed ID: 773300
[TBL] [Abstract][Full Text] [Related]
32. An in vitro culture method for screening new drugs against Mycobacterium leprae.
Dhople AM; Ortega I
Indian J Lepr; 1990; 62(1):66-75. PubMed ID: 2193063
[TBL] [Abstract][Full Text] [Related]
33. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
34. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1992; 72(291):137-42. PubMed ID: 1287401
[TBL] [Abstract][Full Text] [Related]
35. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
Chang YT
Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
[TBL] [Abstract][Full Text] [Related]
36. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
[TBL] [Abstract][Full Text] [Related]
37. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
[TBL] [Abstract][Full Text] [Related]
38. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
39. [Use of tuftsin in experimental leprosy].
Vishnevetskiĭ FE; Freĭdlin IS; Iushchenko AA; Vishnevetskiĭ RF; Anokhina VV; Urliapova NG; Iushin MIu; Eskina IM
Biull Eksp Biol Med; 1991 Aug; 112(8):181-3. PubMed ID: 1786385
[TBL] [Abstract][Full Text] [Related]
40. The effect of ultraviolet light radiation on Mycobacterium leprae.
Truman RW; Gillis TP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):11-7. PubMed ID: 10834064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
